ADHD Archives - HealthQuill

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

by HealthQuill
November 15, 2024
0 Comments

Drugs Health Pharma

High doses of ADHD drugs linked to increased risk of psychosis

HQ Team September 14, 2024: High doses of Attention Deficit and Hyperactivity Disorder (ADHD) medicines can lead to a greater risk of developing.

by HealthQuill
September 14, 2024
0 Comments

Drugs Health Opinion Pharma

Opinion: Proxy parenting not ideal, leads to depression, anxiety in children

The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..

by HealthQuill
September 12, 2024
0 Comments

Drugs Health Pharma

Energy drinks linked to ADHD, anxiety among youth: Study

HQ Team January 20, 2024: Energy drinks have become increasingly popular among teenagers, with over 30% of teens aged 12–17 regularly consuming these.

by HealthQuill
January 20, 2024
3 Comments

Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.

Drugs Health Pharma

First generic versions of Japan’s Takeda ADHD tabs gets FDA nod

HQ Team August 29, 2023: The US Food and Drug Administration has approved several first generics of Takeda Pharmaceutical subsidiary, Shire Plc’s Vyvanse.